The recent biotech stock market is really a tale of two extremes. CRSP and NTLA in hand are still struggling, chasing the dream of gene editing but completely missing the big surge of MLTX and ELVN, watching RVMD hit new highs again, feeling really sour. The ability to tell stories in a bull market is still there, but it's just a matter of whether it's your turn. Every time I think I'm holding onto faith, it turns into internal friction.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
